Powered by


Sep 22, 2018 - The Globe and Mail (Canada)

TILRAY PAST FIVE DAYS STAR Tilray's revenue in the latest quarter: US$9.7-million. Tilray's peak market value during its extraordinary rise - and subsequent plunge - this week: US$28billion. Despite the valuation's complete disconnection from reality, investors were buying the cannabis producer's shares by the kilo on news the University of California plans to use Tilray products to study the drug's effects on patients with a tremor disorder. What we really need is a study of cannabis's effects ...